Philipp Gutzwiller
Director/Board Member at SANTHERA PHARMACEUTICALS HOLDING AG
Net worth: 48 215 $ as of 2024-03-30
Network origin in Philipp Gutzwiller first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
UBS Investment Bank AG
 UBS Investment Bank AG Investment ManagersFinance Part of UBS Group AG, UBS Investment Bank AG is a financial institution based in Geneva, Switzerland. The Swiss company offers a range of banking solutions for private clients, including accounts, mortgages, pension plans, and investment advice. The company also provides expert advice on financial matters for corporate clients and institutions. The company offers digital banking services, including e-banking and mobile banking, and allows customers to send money around the world in 131 currencies. UBS Investment Bank also provides investment views and financial market data. UBS Investment Bank recently acquired Credit Suisse Group AG and is approaching the task in a respectful and timely manner.
3
| Subsidiary | Investment Managers | 3 |
Daiwa Corporate Advisory GmbH
 Daiwa Corporate Advisory GmbH Investment ManagersFinance Daiwa Corporate Advisory GmbH provides financial and investment advisory services. It specializes in all aspects of buy-side and sell-side mergers and acquisitions. The firm also provides ongoing strategic advice. The company was founded in 1991 and is headquartered in Frankfurt, Germany.
2
| Subsidiary | Investment Managers | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Philipp Gutzwiller via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Medical Specialties | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KALA BIO, INC. | Pharmaceuticals: Major | President | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Credit Suisse AG
 Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal | |
| University of Freiburg | College/University | Doctorate Degree | |
Capvis AG
 Capvis AG Investment ManagersFinance Capvis AG (Capvis), formerly known as Capvis Equity Partners AG, is an independent Swiss private equity firm headquartered in Baar, Switzerland, with additional offices in Frankfurt am Main (Germany), Shanghai (China), Jersey (Channel Islands), Luxembourg and Amsterdam (the Netherlands). The firm was established in 1990. | Investment Managers | Private Equity Investor | |
Coller Capital Ltd.
 Coller Capital Ltd. Investment ManagersFinance Coller Capital Ltd (Coller Capital) is a private equity firm founded in 1990 by Jeremy Joseph Coller. The firm is headquartered in London with additional offices in New York, Hong Kong, Beijing, Luxembourg and Seoul. | Investment Managers | Private Equity Investor | |
| Karolinska Institutet | College/University | Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
CVC Advisers Ltd.
 CVC Advisers Ltd. Investment ManagersFinance CVC Advisers Ltd (CVC Advisers) is a private equity firm founded in 1981 by Bruce Hardy McLain, Rolly van Rappard and Steven Koltes. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| University of Basel | College/University | Doctorate Degree Director/Board Member Graduate Degree | |
| University of Fribourg | College/University | Undergraduate Degree | |
| University of Mannheim | College/University | Masters Business Admin | |
| University of Zurich | College/University | Masters Business Admin Graduate Degree Doctorate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Lincoln International LLC
 Lincoln International LLC Regional BanksFinance Lincoln International LLC provides investment banking services. It specializes in strategic advisory services including sell-side mergers and acquisitions, buy-side mergers and acquisitions, debt advisory, growth equity, special situations, valuations and opinions and pensions advisory services. The firm offers capital raising, mergers and acquisitions support, and other corporate finance services. It provides their clients with industry knowledge and access to a comprehensive range of buyers, sellers, and investors. The company was founded in 1996 by Lawrence J. Lawson and is headquartered in Chicago, IL. | Regional Banks | Corporate Officer/Principal | |
| Liverpool John Moores University | College/University | Undergraduate Degree | |
| Aventis Pharma AG | Corporate Officer/Principal | ||
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
| University of Sassari | College/University | Undergraduate Degree | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Big Issue Invest Ltd.
 Big Issue Invest Ltd. Investment ManagersFinance Big Issue Invest Ltd. (Big Issue) is a private equity subsidiary of Big Issue Group founded in 2005. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
Dresdner Kleinwort Ltd.
 Dresdner Kleinwort Ltd. Investment Banks/BrokersFinance Part of Commerzbank AG, Dresdner Kleinwort Ltd. is a brokerage services provider. The private company is based in London, UK. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Clearlab Europe Ltd. | Founder | ||
| Hanken Svenska Handelshögskolan | College/University | Graduate Degree | |
Ciba, Inc
 Ciba, Inc Chemicals: SpecialtyProcess Industries Part of BASF SE, Ciba, Inc develops and produces chemicals, performance products, functional materials, and related goods. | Chemicals: Specialty | Compliance Officer | |
| University of Applied Sciences Basel | College/University | Undergraduate Degree | |
| University of Massachusetts Lowell | College/University | Undergraduate Degree | |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| Alusuisse-Lonza America, Inc. | Director of Finance/CFO | ||
| Caperis Partners AG | Corporate Officer/Principal | ||
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
Xeraya Capital Sdn. Bhd.
 Xeraya Capital Sdn. Bhd. Investment ManagersFinance Xeraya Capital Sdn. Bhd. (Xeraya Capital) is a venture capital firm founded in 2006 by Amirul Fares Wan Zahir. The firm is headquartered in Kuala Lumpur, Malaysia. | Investment Managers | Chief Executive Officer | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Glendower Capital LLP
 Glendower Capital LLP Investment ManagersFinance Glendower Capital LLP (Glendower Capital) is a private equity firm founded in 2017. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Director/Board Member | |
Credit Suisse (Deutschland) AG
 Credit Suisse (Deutschland) AG Investment ManagersFinance Credit Suisse (Deutschland) AG (CS-Deutschland) is the German investment banking subsidiary of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (SW: CSGN, ADR: CS) in Switzerland. Headquartered in Frankfurt, the firm was founded in 1997 and provides a range of financial products and investment advisory services including securities underwriting, placement services, privately negotiated equity investments to institutional, corporate, government, and individual customers worldwide. | Investment Managers | Corporate Officer/Principal | |
| The University of Nottingham Malaysia Campus | College/University | Undergraduate Degree | |
Eisai Srl
 Eisai Srl Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Srl is an Italian company that manufactures and supplies pharmaceutical products. The private company is based in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| Switzerland | 19 |
| United Kingdom | 11 |
| United States | 10 |
| Germany | 6 |
| Italy | 4 |
Sectoral
| Health Technology | 18 |
| Finance | 15 |
| Consumer Services | 13 |
| Commercial Services | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 60 |
| Corporate Officer/Principal | 48 |
| Chairman | 28 |
| Independent Dir/Board Member | 19 |
| Director of Finance/CFO | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Elmar Schnee | 31 |
| Patrick Volkert Vink | 30 |
| Martin Gertsch | 14 |
| Andrew P. Smith | 14 |
| Otto Schwarz | 13 |
| Daniel Wüest | 11 |
| Christoph Rentsch | 10 |
| Dario Eklund | 9 |
| Thomas Meier | 9 |
| Bradley Meyer | 8 |
| Stephanie Brown | 8 |
| Todd Bazemore | 7 |
| Kristina Sjöblom Nygren | 7 |
| Louise Boothby | 7 |
| Shabir Hasham | 6 |
- Stock Market
- Insiders
- Philipp Gutzwiller
- Company connections
